INTRODUCTION
This technical report describes in detail the procedures involved in developing the recommendations for the updated clinical practice guideline on childhood obstructive sleep apnea syndrome (OSAS). 1 The clinical practice guideline is primarily aimed at pediatricians and other primary care clinicians (family physicians, nurse practitioners, and physician assistants) who treat children. The secondary audience for the guideline includes sleep medicine specialists, pediatric pulmonologists, neurologists, otolaryngologists, and developmental/behavioral pediatricians.
The primary focus of the committee was on OSAS in childhood. 2 The committee focused on otherwise healthy children who had adenotonsillar hypertrophy or obesity as underlying risk factors. Complex populations, including infants <1 year of age and children who had other medical conditions (eg, craniofacial anomalies, genetic or metabolic syndromes, neuromuscular disease, laryngomalacia, sickle cell disease), were excluded because these patients will typically require subspecialty referral.
Two professional studies recently published related guidelines: the American Academy of Otolaryngology-Head and Neck Surgery 3 and the American Academy of Sleep Medicine. 4 These guidelines have similar recommendations to many of the recommendations in the American Academy of Pediatrics (AAP) guideline.
The recommendations in this statement do not indicate an exclusive course of treatment. Variations, taking into account individual circumstances, may be appropriate.
METHODS

Literature Search
A literature search was performed that included English-language articles, children and adolescents aged 1 through 17.9 years, and publication between 1999 and 2008. Animal studies, abstracts, letters, case reports, and reviews were excluded. The Medical Subject Heading terms that were used in all fields were snoring, apnea, sleepdisordered breathing (SDB), sleeprelated breathing disorders, upper airway resistance, polysomnography (PSG), sleep study, adenoidectomy, tonsillectomy, continuous positive airway pressure (CPAP), obesity, adiposity, hypopnea, hypoventilation, cognition, behavior, and neuropsychology. Search engines used were PubMed, Scopus, Ovid, PsycINFO, EBSCO (including Health Source [Nursing] , Child Development and Adolescent Studies), and CINAHL. Articles covering special populations (eg, infants aged <1 year, those with craniofacial anomalies or syndromes) were excluded during the title and abstract reviews.
Titles and available abstracts of articles found by the literature search were reviewed by the committee members in several rounds (see Results). In the first round, duplicates and erroneous hits from the literature search were excluded. In the second round, titles were reviewed for relevancy by 2 committee members. Articles with relevant titles were then reviewed by 2 reviewers each, on the basis of the abstract. Because of the large number of remaining articles, text-mining (Statistica, StatSoft version 9; StatSoft, Inc, Tulsa, OK) was performed on the method section of the articles to reduce the large amount of articles for the final step of quality assessment. Text-mining is the combined, automated process of analyzing unstructured, natural language text to discover information and knowledge that are typically difficult to retrieve. 5 Unfortunately, text-mining revealed that few articles reported research methods, such as the study design (eg, clinical case series, retrospective, observational, clinical experiment), blinding of the assessment, and recruitment and/or scoring, that could have been applied for further selection. A manual screening of the questionable articles after text-mining resulted in a pool of 605 articles. The committee decided on a final round of title selection; that is, each member was assigned a random batch of articles and selected titles based on relevance with respect to the guideline categories. These remaining articles were each reviewed and graded by a committee member, as detailed here. Because of the large volume of articles requiring detailed evaluation, some committee members recruited trainees and colleagues to assist them in the performance of these reviews, under their supervision. Jason Caboot, June Chan, Mary Currie, Fiona Healy, Maureen Josephson, Sofia Konstantinopoulou, H. Madan Kumar, Roberta Leu, Darius Loghmanee, Rajeev Bhatia, Argyri Petrocheilou, Harsha Vardhan, and Colleen Walsh participated. A literature search of more recent articles (2008) (2009) (2010) (2011) was performed by individual committee members, per guideline category, and discussed during the committee meeting.
As would be expected from any panel of experts in a field, some of the citations were the work of the panel members. For this reason, a varied panel, including general pediatricians, pulmonologists, otolaryngologists, and sleep medicine physicians, was arranged to provide balance. For initial guideline drafts, committee members were assigned sections of the report that were not directly in their area of research, and the evidence, search results, and conclusions thereof were discussed by all committee members at a face-to-face meeting. Subsequent drafts of the guidelines and technical report were reviewed by all committee members.
Quality Assessment
The previous literature review form 6 was modified to include the evidence grading system developed by the American Academy of Neurology for the assessment of clinical utility of diagnostic tests (Table 1) . 7 A specific customized software (OSA Taskforce; copyright Francesco Rundo and Karen Spruyt) was developed for the literature review form to standardize this part of the process. Of note, the quality assessment levels were comparable to the grading levels applied previously. 8, 9 The quality assessment applied involved 4 tiers of evidence, with level I studies being judged to have a low risk of bias and level IV studies judged to have a very high level of bias. A weaker level of evidence indicates the need to integrate greater clinical judgment when applying results to clinical decision-making. The committee' s quality assessment of data took into account not only the levels of evidence in relevant articles but also the number of articles identified, the magnitude and direction of various findings, and whether articles demonstrated convergent or divergent conclusions.
The evidence-based approach to guideline development requires that the evidence in support of each key action statement be identified, appraised, and summarized and that an explicit link between evidence and recommendations be defined. Evidence-based recommendations reflect the quality of evidence and the balance of benefit and harm that is anticipated when the recommendation is followed. The AAP policy statement "Classifying Recommendations for Clinical Practice Guidelines" 10 was followed in designating levels of recommendations (Fig 1,  Table 2 ).
RESULTS OF LITERATURE SEARCH
The automated Medical Subject Heading search resulted in 3166 hits. After duplicates and erroneous hits were excluded, 2395 hits fulfilled the criteria. After title review, 1091 articles were accepted, with a 0.70 interrater agreement between the 2 reviewers. These remaining articles were reviewed on the basis of the abstract, which resulted in 757 articles remaining, with a 0.60 agreement rate between reviewers. A final decision on those without agreement was made by the chairperson of the committee. Text-mining, although not helpful in reducing the number of articles for further evaluation, illustrated the spectrum of topics covered by the articles (Table 3) . A manual screening of the questionable articles after text-mining resulted in a pool of 605 articles. The final round of title selection resulted in 397 articles for detailed review. An additional 47 articles were found to not meet criteria during the detailed review. Thus, a total of 350 articles were included.
On the basis of the final 350 articles, one-third were epidemiologic studies, 26% were diagnostic studies, and 23% were treatment studies. Table 4 lists the type of study design; 34% of studies were descriptive and 32% were nonrandomized concurrent cohort series. PSG was the diagnostic method used for 57% of the articles, whereas 45% used questionnaires. The sample size varied from 9 to 6742 subjects. Figure 2 shows the level of evidence of the articles; 76% of studies were level III or IV. The majority of studies did not include a control group, which degraded the studies to level III or IV. Few studies applied any form of blinding.
Conclusion
There has been a large increase in the number of published studies since the initial guideline was published. However, there are few randomized, blinded, controlled studies. Most articles evaluated were level III or IV, and many studies were hampered by the lack of a control group. In most studies, blinding was not present or not reported. From a methodologic standpoint, a clear need for randomized clinical trials with blinding is evident.
TERMINOLOGY
OSAS in children is defined as a "disorder of breathing during sleep characterized by prolonged partial upper airway obstruction and/or intermittent complete obstruction (obstructive apnea) that disrupts normal ventilation during sleep and normal sleep patterns," 2 accompanied by symptoms or signs as listed in Table 2 of the accompanying guideline. In this document, the term SDB is used to encompass Level Description I Evidence provided by a prospective study in a broad spectrum of persons who have the suspected condition, by using a reference (gold) standard for case definition, in which the test is applied in a blinded fashion, and enabling the assessment of appropriate test of diagnostic accuracy. All persons undergoing the diagnostic test have the presence or absence of the disease determined. Level I studies are judged to have a low risk of bias. II Evidence provided by a prospective study of a narrow spectrum of persons who have the suspected condition, or a well-designed retrospective study of a broad spectrum of persons who have an established condition (by gold standard) compared with a broad spectrum of controls, in which the test is applied in a blinded evaluation, and enabling the assessment of appropriate tests of diagnostic accuracy. Level II studies are judged to have a moderate risk of bias. III Evidence provided by a retrospective study in which either persons who have the established condition or controls are of a narrow spectrum, and in which the reference standard, if not objective, is applied by someone other than the person who performed (interpreted) the test. Level III studies are judged to have a moderate to high risk of bias. IV Any study design where the test is not applied in an independent evaluation or evidence is provided by expert opinion alone or in descriptive case series without controls. There is no blinding or there may be inadequate blinding. The spectrum of persons tested may be broad or narrow. Level IV studies are judged to have a very high risk of bias.
both snoring and OSAS when studies did not distinguish between these entities.
PREVALENCE OF OSAS
The original clinical practice guideline found a prevalence of OSAS of 2% (3 studies) and a prevalence of habitual snoring (HS) of 3% to 12% (7 studies). Since publication of the original guideline, 10 studies (in 12 separate articles) used the gold standard of conventional overnight laboratory PSG to diagnose OSAS (Table 5) . These studies were all levels I through IV, depending on the size and characteristics of the sample population, and represented many countries and age groups. They used various criteria, not all of which are standard, to diagnose OSAS. Many of the studies had a small sample size and/or studied only a selected high-risk sample of the population. Despite these limitations, the 10 studies found a prevalence of OSAS in the general pediatric population of 0% to 5.7%. Three studies to note were those of Bixler et al 11 from the United States, Li et al 12 from China, and O'Brien et al 13 from the United States. These 3 studies (levels I-II) had large sample sizes from the general pediatric population and reported OSAS prevalence rates of 1.2% to 5.7%. Six studies investigated the prevalence of OSAS by using various ambulatory studies rather than full, laboratorybased PSG (Table 6 ). Although the sample sizes were generally larger, home studies are not considered the gold standard of diagnosis and were thus level III. These studies found an OSAS prevalence of 0.8% to 24%. The 2 outliers (at 12% and 24%) 14, 15 used more liberal criteria to diagnose OSAS. Excluding those studies, the OSAS prevalence was 0.8% to 2.8%.
Several studies attempted to discern variables associated with the presence of OSAS. Three studies found an equal prevalence between males and females, [16] [17] [18] and 2 studies found an increased prevalence in males. 12, 15 Two studies reported an increased risk in children of ethnic minorities, 11, 19 supporting older data. 20 Four studies found an increased risk in obese patients, 12, 17, 21, 22 but 3 studies did
FIGURE 1
Evidence quality. Integrating evidence quality appraisal with an assessment of the anticipated balance between benefits and harms if a policy is carried out leads to designation of a policy as a strong recommendation, recommendation, option, or no recommendation. RCT, randomized controlled trial. Strong recommendation A strong recommendation in favor of a particular action is made when the anticipated benefits of the recommended intervention clearly exceed the harms (as a strong recommendation against an action is made when the anticipated harms clearly exceed the benefits) and the quality of the supporting evidence is excellent. In some clearly identified circumstances, strong recommendations may be made when high-quality evidence is impossible to obtain and the anticipated benefits strongly outweigh the harms.
Clinicians should follow a strong recommendation unless a clear and compelling rationale for an alternative approach is present.
Recommendation
A recommendation in favor of a particular action is made when the anticipated benefits exceed the harms but the quality of evidence is not as strong. Again, in some clearly identified circumstances, recommendations may be made when highquality evidence is impossible to obtain but the anticipated benefits outweigh the harms.
Clinicians would be prudent to follow a recommendation but should remain alert to new information and sensitive to patient preferences.
Option
Options define courses that may be taken when either the quality of evidence is suspect or carefully performed studies have shown little clear advantage to 1 approach over another.
Clinicians should consider the option in their decision-making, and patient preference may have a substantial role.
not. 15, 16, 23 Another study reported an increased risk of OSAS with increased waist circumference, a marker for obesity. 11 One study found an increased risk with nasal abnormalities, 11 1 study found an increased risk with prematurity, 19 and 2 studies found increased risk with adenotonsillar hypertrophy. 12, 22 Multiple studies (levels II-IV) investigated the prevalence of HS, which is one of the most prominent manifestations of OSAS ( Table 7) . The presence of snoring was based on parental or personal questionnaires. Not all of the questionnaires used have been validated, and the data relied on subjective responses rather than objective clinical evaluations. The reported prevalence of HS varied widely, depending on the study and definition used, from 1.5% to 27.6%.
In summary, studies of OSAS and HS show varied prevalence rates, depending on the population studied, the methods used to measure breathing during sleep, and the definitions used for diagnosis. Nevertheless, the preponderance of evidence suggests a prevalence of OSAS in the range of 1% to 5%, making this a relatively common disease that would be encountered by most clinicians in primary practice.
Areas for Future Research
Population-based studies on the gender and race distribution of OSAS among different age groups.
SEQUELAE OF OSAS
Neuropsychological and Cognitive Problems Associated With OSAS
Of the 350 articles related to this search over the last 10 years, 61 articles directly explored the relationship between SDB and cognitive or neuropsychological deficits. In total, 29 658 subjects were studied, including 2 level I studies 24, 25 with a total of 174 subjects and 5 level II studies. [26] [27] [28] [29] [30] The diagnosis of SDB was based on clinical symptoms in 29 articles and on PSG in 32 articles.
Cognitive Deficits
All but 1 study (level IV) 31 demonstrated deficits in cognition or neuropsychological function in association with symptoms, signs, or diagnosis of SDB. The 1 exception examined children who had mild OSAS over a wide age range and did not include behavioral assessments. In this study, the mean IQ in the OSAS population was significantly above the standard mean. Some [32] [33] [34] but not all studies showed a correlation between the severity of obstructive apnea as measured on PSG and increasing neuropsychological morbidity. There are several reasons why correlations were not found for all studies. Standard PSG was developed to detect cardiorespiratory variations and may not be an adequate tool for detection of sleep changes that affect neuropsychological function. Another possibility is that any degree of SDB is associated with abnormal neuropsychological outcomes and might be affected variably by social, medical, environmental, or socioeconomic factors not measured by using PSG. This 
FIGURE 2
Levels of evidence of articles used for this report.
e718 FROM THE AMERICAN ACADEMY OF PEDIATRICS possibility is confirmed by a recent level I study showing that obesity, OSAS, and neurocognitive outcomes are all interdependent. 35 Furthermore, most studies were not controlled for socioeconomic status (SES), which is important because SES strongly affects the results of neurocognitive testing and because OSAS is associated with low SES. 36 Although some studies have shown abnormalities in snorers compared with nonsnoring controls, in many of these studies, data in snorers still fell within the normal range. 24 In addition, cutoffs for OSAS used in some studies resulted in a blurring of boundaries between the OSAS and snoring groups. For example, Chervin et al used an obstructive apnea index cutoff of only ≥0.5/hour to define OSAS, and the mean apnea index for the OSAS group was 2.9 events/hour, indicating that the study group had mild OSAS, which was not that different from the snorers. 37, 38 A study with a wider spectrum of severity may have attained different results. Finally, most studies have not controlled for obesity, which has been associated with neurobehavioral and cognitive abnormalities.
Although most studies simply compared groups, others have looked at the correlation between polysomnographic indices and neurocognitive/ behavioral outcomes and have shown a correlation between different polysomnographic factors and cognitive outcomes, behavioral outcomes, and sleepiness. [32] [33] [34] 39 Cognitive deficits associated with pediatric SDB include general intelligence level as well as processes measured by using IQ subtests (Table 8) . Specific functions objectively measured by using neuropsychological assessments and included in the research studies include:
Learning, memory, and visuospatial skills 226 Kaemingk et al 33 Kennedy et al 34 Kurnatowski et al 227 Carvalho et al 228 III 1332 Objective measures of general intelligence, verbal skills affected by SDB Montgomery-Downs et al 50 Suratt et al 43 Friedman et al 26 II 45 Additive factors were SES and ethnicity 42 , 45 or BMI, 42 , 45 , 47 which contributed to findings of poor school performance in SDB Kaemingk et al 33 Ng et al 219 Perez-Chada et al 220 Shin et al 47 Urschitz 232 Kaemingk et al 33 Kennedy et al 34 Kurnatowski et al 227 O'Brien et al 233 Spruyt et al 234 Giordani et al 38 Halbower et al 28 233 Objective testing performed in all studies Perez-Chada et al 220 Honaker et al 235 Lundeborg et al 51 Suratt et al 43 III 236 Galland et al 237 Gottlieb et al 213 Hamasaki Uema et al 232 Kaemingk et al 33 Li et al 238 Mulvaney et al 32 Urschitz et al 229 Chervin et al 37 I 105 O'Brien et al 24 I 118 Visual and auditory attention and working memory. Executive functions are required for optimal school performance and are acquired through adolescence in developing children.
Behavioral Abnormalities
The investigations on the cognitive effects of SDB in the 61 studies often included measures of neurobehavioral outcomes (Table 9 ). Hyperactivity was the most commonly studied and/or reported behavioral abnormality associated with SDB. It was reported as a frequent symptom of SDB in younger children, and in fact, in 1 study, snoring was found to be strongly predictive of a future diagnosis of hyperactivity over the long-term (level IV). 40 Attentiondeficit/hyperactivity disorder (ADHD) or ADHD symptoms, hypersomnolence, somatization, depression, atypicality, aggression, and abnormal social behaviors were the other most frequently reported behavioral abnormalities associated with SDB in children.
Most behavioral difficulties were defined by using parent or teacher questionnaires in unblinded level IV studies.
Sleepiness
Two studies (levels I-II) have shown a relationship between polysomnographic measures and objective measurement of daytime sleepiness on multiple sleep latency testing. 27 50 and level IV 37 studies (Table 10) . Of concern, however, is that some recent articles suggest that certain deficits of cognition measured by using objective testing may not improve to a large extent after treatment of childhood OSAS. Language, IQ, and executive function did not improve significantly in a well-designed, controlled study of 92 children (level II). 30 General intelligence in at-risk populations improved in 1 study (level III), 50 but phonologic processes and verbal fluency did not improve to normal (level III 50 and level IV 51 ). QoL increases after treatment. 37, [52] [53] [54] [55] [56] [57] [58] Three studies demonstrated long-term (≥1 year) behavioral or QoL improvements. 37, 52, 53 The majority of these studies suggest that in developing children who are dependent on executive function, cognition, and behavioral skills for daily function and school performance, treatment of childhood SDB has benefits.
Conclusion
In summary, these studies suggest that, in developing children, early diagnosis and treatment of pediatric OSAS may improve a child' s long-term cognitive and social potential and school performance. These findings imply that the earlier a child is treated for OSAS, the higher the trajectory for academic and, therefore, economic success, but research is needed to support that implication. There is demonstrated benefit in terms of behavior, attention, and social interactions, as well as likely improvement in cognitive abilities with the treatment of pediatric OSAS. However, more long-term studies are needed. The risks of treatment depend on the type of treatment but include risk of surgery, risk of medication, nonadherence to therapy, and cost. 
Areas for Future Research
Further research is required to determine which domains of cognitive function will improve with treatment of OSAS. Reversibility of cognitive deficits associated with OSAS must be adjusted for the confounding effects of age, length of symptoms, SES, BMI, sleep duration, environment, and race and ethnicity.
Cardiovascular Effects of OSAS
A total of 24 studies related to cardiovascular effects of OSAS in childhood were identified since the last review. The levels of evidence were III and IV.
In a retrospective, level IV study of 271 clinical cases, only 1 child, who had congenital heart disease, had signs of cardiac failure preoperatively, and other cases had no evidence of left or right ventricular hypertrophy. 59 However, studies using more sophisticated, prospective techniques have found subclinical evidence of cardiac dysfunction. These studies are described in Table 11 . Although postoperative adenotonsillectomy (AT) cardiac complications are rare (level IV), 59 left and right ventricular hypertrophy is significantly associated with postoperative respiratory complications (level III), 60 supporting the recommendation in the current and the previous guidelines that children who have cardiac abnormalities be monitored as inpatients postoperatively.
Blood pressure (BP) has also been shown to be affected by OSAS in children. There were 9 recent level III or IV studies, most of which showed a correlation between the presence/ 40 Galland et al 237 Golan et al 239 Gottlieb et al 213 Johnson and Roth 45 LeBourgeois et al 230 Mitchell and Kelly 240 Owens et al 189 Roemmich et al 191 Urschitz et al 229 Montgomery 240 Mitchell and Kelly 241 Rudnick and Mitchell 242 Suratt et al 43 III 114 O'Brien et al 24 I 118 Behavior problems, general Goldstein et al 55 IV 1946 Behavior generally measured by using parent questionnaire Goldstein et al 243 Hogan et al 48 Li et al 238 Mitchell and Kelly 241 Mulvaney et al 32 Owens et al 189 Roemmich et al 191 Rosen et al 244 Rudnick and Mitchell 242 Tran et al 58 Wei et al 245 Aggression, oppositional and social problems
Chervin et al 246 IV 4407 Gottlieb et al 213 Galland et al 237 Mitchell and Kelly 240 Mulvaney et al 32 O'Brien et al 24 I 118 Excessive daytime sleepiness Goodwin et al 212 IV 9729 Sleepiness measured by using questionnaire Perez-Chada et al 220 Shin et al 47 Urschitz et al 229 Johnson and Roth 45 Gozal et al 27 severity of OSAS and indices of elevated BP (Table 12 ).
In a study by Kaditis et al, 61 overnight changes in brain natriuretic peptide levels were large in children who had an apnea hypopnea index (AHI) ≥5/ hour when compared with those with milder OSAS and with controls (level III). This finding suggests the presence of nocturnal cardiac strain in children who have moderate to severe OSAS.
Two studies evaluated brain oxygenation and cerebral artery blood flow. Khadra et al 62 reported that male gender, arousal index, and amount of non-rapid eye movement sleep were associated with diminished cerebral oxygenation, whereas increasing mean arterial pressure, age, oxygen saturation (SpO 2 ), and amount of rapid eye movement sleep were associated with augmented cerebral oxygenation (level III). Hogan et al 48 found a decrease in middle cerebral artery velocity postoperatively in patients treated for OSAS, whereas control subjects showed a slight increase over time (level IV).
Three studies evaluated autonomic variability in children who have OSAS.
Constantin et al 63 reported resolution of tachycardia and diminished pulse rate variability after AT in children who had OSAS (diagnosis of OSAS based on oximetry plus questionnaire data) (level IV). Deng et al 64 studied heart rate variability and determined that heart rate chaos was modulated by OSAS as well as by sleep state (level IV). In a study of 28 children who had OSAS, O'Brien and Gozal 65 found evidence of altered autonomic nervous system regulation, as evidenced by increased sympathetic vascular reactivity, during wakefulness in these children (level III). These studies all suggest that OSAS places stress on the autonomic system.
In summary, a large number of studies, albeit primarily level III, found that cardiac changes occur in the presence of OSAS, with an effect on both the right and left ventricles. OSAS in childhood also has an effect on both systolic and diastolic BP. In addition, several studies suggest that childhood OSAS can affect autonomic regulation, brain oxygenation, and cerebral blood flow. These studies suggest that childhood OSAS may jeopardize longterm cardiovascular health. 66 The association between left ventricular remodeling and 24-hour BP highlighted the role of SDB in increasing cardiovascular morbidity.
Areas for Future Research
How reversible, after treatment, are cardiovascular changes in children who have OSAS?
What are the long-term effects of OSAS on the cardiovascular system? 238 Mitchell and Kelly 240 Mitchell and Kelly 241 Roemmich et al 191 Chervin et al 37 I 105 Long-term improvement in hyperactivity Somatization, depression
Galland et al 237 IV 153 All showed improvement in depression and/or somatization Mitchell and Kelly 240 Mitchell and Kelly 241 Behavior problems, general
Goldstein et al 55 IV 450 All showed behavior improvement except Davis et al 49 Goldstein et al 243 Long-term behavior improvement in Mitchell et al 53 Hogan et al 48 Li et al 238 Roemmich et al 191 Tran et al 58 Wei et al 245 Mitchell et al 53 Davis et al 49 Aggression, oppositional, and social problems 54 Long-term improvements ≥1 y 52 , 53 Goldstein et al 55 Sohn et al 56 Silva and Leite 57 Tran et al 58 Chervin et al 37 I 105 Long-term improvements at 1 y Sleep quality Constantin et al 54 IV 590 Improved in both studies Wei et al 245 
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Growth
The section on obesity contains a detailed review of obesity and OSAS, including the relationship between OSAS and the metabolic syndrome. The previous guideline documented many studies showing a relationship between OSAS and growth, and an increase in growth parameters after treatment of SDB by AT; this outcome has been confirmed by a number of more recent studies (as discussed in the recent meta-analysis by Bonuck et al 67 ) . In a confirmation of previous reports, 68, 69 Selimo glu et al 70 found a decreased level of serum insulin-like growth factor-I in children who have OSAS, which increased significantly 6 months after AT (level III).
Inflammation
Since the publication of the 2002 AAP guideline, there has been growing research on the role of OSAS in systemic inflammation. It has been postulated that OSAS results in intermittent hypoxemia, leading to production of reactive oxygen species. In addition, the hypoxemia and arousals from sleep lead to sympathetic activation. These factors may trigger inflammation or exacerbate obesity-related inflammation. However, the data on OSAS and markers of systemic inflammation in children are scarce and contradictory.
Eight studies (level II-III) measured levels of C-reactive protein (CRP) in children who had OSAS. Four studies (including 2 from the same center) showed no relationship between CRP and OSAS, 71-74 whereas 4 studies (2 from the same center) did show a relationship. 46, [75] [76] [77] Part of the discrepancy between studies may be attributable to the varying proportions of obese subjects (because obesity is associated with high CRP levels) and varied age of subjects and definitions of OSAS in the different studies. Some studies controlled for obesity and degree of OSAS, whereas others did not. The studies showing a positive relationship indicated that OSAS was associated with elevated CRP levels only above a certain threshold of severity. Thus, the relationship between OSAS and CRP seems to be complex and is affected by obesity and severity of OSAS.
A few level II and III studies have evaluated other circulating markers of inflammation in children who have OSAS. Two studies showed no difference in circulating intercellular adhesion molecule-1 between patients with OSAS and controls. 71, 73 A single study found elevated p-selectin (a measure of platelet activation) in children who had OSAS compared with controls. 73 A single study showed elevated levels of interferon-γ in children who had OSAS. 74 One study showed increased interleukin (IL)-6 and lower IL-10 in those with OSAS, 78 whereas another study did not. 74 Another study reported no difference in cytokines IL-1β, IL-2, IL-4, IL-8, IL-12, and granulocyte macrophage colonystimulating factor levels between children who had OSAS and controls. 74 Data on tumor necrosis factor-α are conflicting, 74, 79 and differences in levels may be related to tumor necrosis factor-α gene polymorphisms. 80 A pathology-based study found increased glucocorticoid receptors in adenotonsillar tissue from children who had OSAS compared with tissue from children who experienced chronic throat infections (level III) 81 ; another study from the same group found elevated leukotriene receptors (level IV). 82 These findings provide a theoretical construct for the potential utility of antiinflammatory drugs as treatment of children who have OSAS, although possibly not for those who have already undergone AT.
In summary, the data on CRP are conflicting, but it may be that CRP levels increase above a certain threshold of severity of OSAS. Further research involving large samples of subjects who have varying degrees of OSAS severity, with results controlled for BMI and age, are needed. There are too few data on other circulating markers of systemic inflammation to enable any recommendations.
Areas for Future Research
Larger studies, stratified for the severity of OSAS and controlled for obesity, are required to determine whether OSAS is associated with systemic inflammation. If so, what are the long-term sequelae of this inflammation? Are inflammatory biomarkers potential good outcome measurements for OSAS treatment studies? Do they correlate with clinical outcomes or longterm prognosis?
METHODS OF DIAGNOSIS
The previous guideline discussed the diagnosis of OSAS in great detail. On the basis of published evidence at the time, it was concluded that the positive and predictive value of history and physical examination for the diagnosis of OSAS was 65% and 46%, respectively; that is, no better than chance. It was therefore recommended that objective testing be used for the diagnosis of OSAS. An evaluation of the literature regarding nocturnal pulse oximetry, video recording, nap PSG, and ambulatory PSG suggested that these methods tended to be helpful if results were positive but had a poor predictive value if results were negative. Thus, children who had negative study results should be referred for more comprehensive testing. These recommendations were based on only a few studies, most of which had a low level of evidence. Furthermore, it was recognized that these techniques were of limited use in evaluating the severity of OSAS (which is important in determining management, such as whether outpatient surgery can be performed safely). In 84 performed slightly better than other published questionnaires, with a sensitivity of 0.85 and a specificity of 0.87 by using a set cutoff. A follow-up study by the same group showed a sensitivity of 78% and a specificity of 72% for PSG-defined OSAS. 85 However, this is still a relatively low sensitivity and specificity for clinical purposes. By using this instrument, the same group also found that negative answers to only 2 questions on the Pediatric Sleep Questionnaire were helpful in identifying patients who had normal PSG results. 86 Taken together, the overall performance of questionnaire tools seems to support their use more as a screening tool than as a diagnostic tool, such that a negative score would be unlikely to mislabel a child with OSAS as being healthy, but a positive score would be unlikely to accurately diagnose a particular child with certainty.
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Utility of Clinical Evaluation for the Diagnosis of OSAS
Similar to the data presented in the previous guideline, most studies found that clinical evaluation was not predictive of OSAS on PSG. Godwin et al 15 performed a large (N = 480), population-based study of 6-to 11-yearold children. The study included use of a standardized history, some clinical parameters, and ambulatory, full PSG (level II). They concluded that the sensitivity of any individual or combined clinical symptoms was poor. Certain parameters, such as snoring, excessive daytime sleepiness, and learning problems, had a high specificity.
In a level III study, van Someren et al 87 compared history and clinical examination by a pediatrician or otolaryngologist with abbreviated PSG (video recording, oximetry, and measurement of snoring). Both the sensitivity and specificity of the clinician' s impression of moderate/severe OSAS were low (59% and 73%, respectively).
In a similar number of cases, the clinicians underestimated (17%) and overestimated (16%) study results.
In a level III study, it was shown that waist circumference z score had a statistically significant but clinically poor correlation with symptoms of OSAS (R = 0.32, P = .006); BMI z score did not correlate with symptoms. 88 
Radiologic Studies
Several studies, all level III or IV, evaluated the utility of radiologic examinations in addition to clinical factors in establishing the diagnosis of OSAS (Table 13) . Overall, these studies showed that the presence of airway narrowing on a lateral neck radiograph increased the probability of predicting OSAS on PSG. Cephalometric studies tended to show a small mandible in patients who had OSAS compared with controls, although a study using an MRI did not confirm this. 89 None of the cephalometric studies provided sensitivity and specificity or positive and negative predictive values. Table 13 simplifies the cephalometric findings for the purpose of presentation. A level I study indicated that acoustic pharyngometry may be a useful screening technique for OSAS in older children, but approximately one-half of the children could not cooperate well with the testing. 90 One uncontrolled study (level IV) showed that nasal resistance, as measured by using rhinometry, had a high sensitivity and specificity for predicting polysomnographic OSAS. 91 This technique warrants further study and validation.
Snoring Evaluation
Two level IV studies found a weak association between objective snoring characteristics and the presence/ severity of OSAS that was insufficient to assist in clinical diagnosis. 92, 93 Cardiovascular Parameters
Studies have evaluated the utility of screening tests based on heart rate or other vascular factors in predicting OSAS (Table 14) . These studies ranged from studies of pulse rate alone to more sophisticated (and, hence, more expensive or time-consuming) studies, such as analyses of heart rate variability, pulse transit time, and peripheral arterial tonometry. Studies were level II through IV. Overall, the studies found changes in cardiovascular variables in children who had OSAS but with varying sensitivities and specificities. Thus, some of these measures may potentially be useful screening tests in the future if combined with other modalities that would increase the sensitivity and specificity but cannot be recommended for clinical use at this point.
Nocturnal Oximetry
The previous AAP guideline, on the basis of a single study by Brouillette et al, 94 indicated that nocturnal pulse oximetry could provide an accurate screen for OSAS if the result was positive but that full PSG was needed if the oximetry result was negative. A need for further research in this area was indicated. Four additional studies were identified for the current report. Two of these did not compare oximetry versus PSG and therefore will not be discussed further. 95, 96 A follow-up study (level II) from the same group as the previous report by Brouillette et al 94 used overnight oximetry, primarily obtained in the home, to develop a scoring algorithm. 97 The subjects' median age was 4 years. The oximetry score correlated with the AHI obtained from PSG as well as with the presence of postoperative complications. However, the positive predictive value of oximetry for major postoperative respiratory compromise was only 13%. Of note, 80% of the 223 children had normal, inconclusive, or technically unsatisfactory oximetry results and were therefore referred for either repeat oximetry or PSG. In contrast, Kirk et al 98 compared overnight home oximetry (by using a system with an automated oximetry analysis algorithm that provided a desaturation index) with laboratory PSG in 58 children aged ≥4 years who had suspected OSAS (level III). They found poor agreement between the desaturation index on the basis of oximetry and the PSG-determined AHI. The sensitivity of oximetry for the identification of moderate OSAS (AHI >5/hour) was 67%, and specificity was 60%. The oximetry algorithm tended to overestimate the AHI at low levels and underestimate at high levels. The authors concluded that oximetry alone was not adequate for the diagnosis of OSAS. On the basis of these limited studies, it seems as if oximetry alone is insufficient for the diagnosis of OSAS because of the high rate of inconclusive test results and the poor sensitivity and specificity compared with PSG, probably, in part, because children may have OSAS that results in arousals and sleep fragmentation but little desaturation. In addition, children tend to move a lot during sleep, which can result in movement artifact.
Ambulatory PSG
The term "ambulatory PSG" is used for unattended sleep studies conducted in the home. Frequently, ambulatory PSG consists of cardiorespiratory recordings alone. Although the use of ambulatory PSG is considered appropriate under certain circumstances in adults, 99 there is a paucity of studies evaluating ambulatory PSG in children. Zucconi et al 100 evaluated a home portable system comprising measurements of airflow (by using thermistry), snoring, chest and abdominal wall movements, electrocardiography (ECG), position, and oximetry (level II). However, the portable system was used in the sleep laboratory for the purpose of the study. A small sample of 12 children, 3 to 6 years of age, underwent routine PSG and in-laboratory portable testing on a consecutive night with the portable system. The portable system had good sensitivity for detecting a respiratory distress index (RDI) >5/hour (78% with automated scoring; 89% with human scoring) but a specificity of zero. Rosen et al 19 reported on a study of 664 children aged 8 to 11 years who underwent abbreviated ambulatory study (by using inductance plethysmography, oximetry, heart rate, and position) (level III). Of these home studies, 94% were considered technically adequate. A subsample of 55 children also underwent full laboratory PSG. Few details were given regarding this subsample. However, it was reported that the ambulatory studies had a sensitivity PSG allows patients to be stratified in terms of severity, which helps determine which children are at risk for sequelae (thus alerting pediatricians to screen for complications of OSAS); which children are at risk for postoperative complications and would, therefore, benefit from inpatient observation postoperatively; and which children are at high risk of persistence of OSAS postoperatively, who may then need postoperative PSG to assess the need for further treatment (eg, CPAP).
Adult patients may sleep poorly the first time they are in a sleep laboratory because of anxiety, the unfamiliar environment, and the attached sensors. This "first night effect" can lead to altered sleep architecture and possible underestimation of the severity of OSAS. Five studies (levels I-IV) evaluated the night-to-night variability of PSG in children 101, [103] [104] [105] [106] ; in one of these articles, 101 only a small subsample had night-to-night variability evaluated (Table 15 ). The time difference between PSGs varied from 24 hours to 4 weeks. Although some of the studies showed minor differences in respiratory parameters from night to night, the studies suggest that few children would have been clinically misclassified on the basis of a single night' s PSG. Thus, 1 night of PSG seems to be adequate to establish the diagnosis of OSAS. All studies showed significant differences in sleep architecture from night to night. Therefore, research studies evaluating sleep architecture would require >1 night of PSG. For consistency, it is recommended that PSG be performed and scored by using the pediatric criteria from the American Academy of Sleep Medicine scoring manual. 107 
Other Tests
The shape of the maximal flow-volume loop on pulmonary function testing has been used to attempt to screen for OSAS in adults. Young children cannot perform standard maximal flowvolume loops. One small study of 10 subjects evaluated the relationship between tidal breathing flow-volume loops and PSG (level III). 108 The sensitivity was 37.5% and specificity was 100%, indicating that this method is of limited utility in screening for OSAS.
Two studies by the same group evaluated whether urinary/serum proteinomic analysis could be used to screen for the presence of OSAS. In a level I study of urinary proteinomics, the investigators found that a combination of urinary proteins could predict OSAS with a sensitivity of 95% and a specificity of 100%. 109 Similarly, in a level III study from the same group, the investigators found that a different set of proteins could be used to identify 15 of 20 children who had OSAS and 18 of 20 children who were snorers. 110 The authors note that they studied a highly selected population matched for age, gender, ethnicity, BMI, and inflammatory respiratory disorders, such as allergic rhinitis or asthma. Thus, this technique, although promising, requires further validation in typical clinical cohorts and duplication in another laboratory.
Summary
In summary, few of the screening techniques mentioned here have a sensitivity and specificity high enough to be relied on for clinical diagnosis. In addition, it should be noted that many of the studies used an AHI >5/hour when determining sensitivity and specificity, although an AHI >1.5/hour is considered statistically abnormal in children. [111] [112] [113] Few studies used large study samples, and few were blinded. As a result, some of the studies of screening techniques resulted in contradictory evidence. On a pragmatic level, however, it is realized that current infrastructure is inadequate to provide PSG for all children with suspected OSAS. Therefore, the use of screening tests may be better than no objective testing at all. However, clinicians using these tests should familiarize themselves with the sensitivity and specificity of the test used and consider proceeding to full PSG if the test result is inconclusive.
Areas for Future Research
Well-designed, large, controlled, blinded, multicenter, prospective studies are required to provide more definitive answers regarding the utility of screening tests for the diagnosis of OSAS. In particular, additional studies of ambulatory PSG in children of varying ages are needed.
TREATMENT OF OSAS AT
Adenotonsillar hypertrophy is the most common cause of OSAS, and AT continues to be the primary treatment for this issue. Adenoidectomy alone may not be sufficient for children who have OSAS because it does not address oropharyngeal obstruction secondary to tonsillar hyperplasia. The previous guideline stated the importance of AT as the primary treatment for OSAS in children. No new literature is available to suggest a change to these recommendations. Table 3 in the guideline lists relative contraindications to AT. Note that whereas a submucus cleft palate is a relative contraindication to adenoidectomy, a partial adenoidectomy may be performed in such patients. However, postoperative PSG should be performed to ensure that OSAS has resolved.
AT in most children is associated with a low complication rate. Minor complications include pain and poor oral intake. More severe complications may include bleeding, infection, anesthetic complications, respiratory decompensation, velopharyngeal incompetence, subglottic stenosis, and, rarely, death.
Tarasiuk et al found that health care utilization costs were 226% higher in children with OSAS before diagnosis compared with control children 114 and that health care costs decreased by one-third in children who underwent AT, whereas there was no change in health care costs in control children or children who had untreated OSAS 115 (both studies were level IV).
Partial Tonsillectomy
Several newer techniques for tonsillectomy have gained increasing use since publication of the last guideline. The primary goal of these techniques An important advantage of the objective documentation of the severity of OSAS by using PSG should be the ability to predict the need for overnight hospital stay after AT on the basis of a higher risk of postoperative complications. Severe OSAS has been proposed as a criterion for inpatient observation; the current evidence to define severe OSAS is derived primarily from level III retrospective studies. Although considerable physiologic information regarding the respiratory pattern and gas exchange during sleep is available from an overnight PSG, the available studies have focused primarily on the AHI and, to a lesser degree, the nadir of the SpO 2 . Relevant studies are listed in Table 16 . Studies varied with regard to the type of patients included (proportion of obese patients; patients who had craniofacial and genetic syndromes) and severity of OSAS. Although the definition of postoperative respiratory compromise varied, most studies required that an intervention (eg, supplemental oxygen, nasopharyngeal tube, CPAP, intubation) be performed. Most studies found a high rate of postoperative respiratory complications. Different studies showed different PSG predictive factors for postoperative complications, and few studies developed receiver operating characteristic curves. 127 Nevertheless, studies were fairly consistent in indicating that an SpO 2 <80% and an AHI >24/hour were predictive of postoperative respiratory compromise. These criteria are more conservative than the recently published clinical practice guidelines from the American Academy of Otolaryngology-Head and Neck Surgery, which recommend that children who have an AHI ≥10/hour and/or an SpO 2 nadir <80% be admitted for overnight observation after AT. 3 It is difficult to provide exact PSG criteria for OSAS severity because these criteria will vary depending on the age of the child; additional comorbidities, such as obesity, asthma, or cardiac complications of OSAS; and other PSG criteria that have not been evaluated in the literature, such as the level of hypercapnia and the frequency of desaturation (compared with SpO 2 nadir). Therefore, on the basis of published studies ( compared children who had a URI within 2 weeks of surgery versus those without a URI; 27% of children had a recent URI. They found a doubling of the incidence of laryngospasm, bronchospasm, and oxygen desaturation intraoperatively and in the recovery room in the children who had recent URIs, although the overall incidence of these events was low. The risk was highest in young children; those undergoing ear, nose, and throat surgery; and those in whom multiple attempts were made to insert the laryngeal mask airway. On the basis of data available regarding risk with general anesthesia, the committee concluded that children who have an acute respiratory infection on the day of surgery, as documented by fever, cough, and/ or wheezing, are at increased risk for postoperative complications and, therefore, should be rescheduled or monitored closely postoperatively. Clinicians should decide on an individual basis whether these patients should be rescheduled, taking into consideration the severity of OSAS in the particular patient and keeping in mind that many children who have adenotonsillar hypertrophy exhibit chronic rhinorrhea and nasal congestion even in the absence of viral infections.
Postoperative Persistence of OSAS After AT
Although the majority of children have a marked improvement in OSAS after AT, OSAS may persist postoperatively. OSAS is especially likely to persist in children who have underlying illnesses such as craniofacial anomalies, Down syndrome, and neuromuscular disease; these special populations are not included in this review.
Over the years since the committee' s first consensus report, a number of studies have been published discussing the impact of surgery on childhood OSAS. Most of these studies were omitted from consideration for cles, but more importantly, because the postoperative prevalence of OSAS is highly dependent on the stringency of diagnostic criteria. In some cases, articles helpfully provided data on residual prevalence of OSAS by using different polysomnographic criteria (eg, AHI >1/hour and AHI >5/hour). At this point, it is generally accepted that AT has a higher success rate than isolated adenoidectomy or tonsillectomy, so although a few of the articles included some patients undergoing only adenoidectomy, only tonsillectomy, or ancillary procedures such as nasal turbinectomy, most focused exclusively on the impact of AT.
As shown in Table 17 , a total of 11 articles were published, describing 10 general population cohorts referred either to a pediatric sleep specialist or otolaryngologist for OSAS, and 1 meta-analysis of articles dating back to 1980. Most of these were case series of patients, with significant methodologic flaws, including nonblinding and incomplete follow-up for a high proportion of patients, and these issues were present even in the methodologically strongest articles. [132] [133] [134] The polysomnographic criteria for OSAS in each article may or may not have been the same as those used as an indication for AT, and these varied from an AHI ≥1/hour to AHI ≥5/hour and RDI >2 to 5/hour. Surprisingly, the overall estimate of postoperative persistence of OSAS did not seem to vary greatly by polysomnographic criteria for surgery. Conversely, the estimates of residual OSAS were clearly related to which polysomnographic criteria for OSAS were applied to the postoperative PSGs. When using an AHI ≥1/hour as the criterion for residual OSAS, estimates of persistence ranged from 19% 135 to 73%, 133 whereas when using an AHI ≥5/hour as the criterion, the estimate of persistence of OSAS ranged from 13% 134 to 29%. 132 It is important to recognize that there are clearly recognizable risk factors for postoperative persistence of OSAS and that the prevalence of these risk factors in the populations studied had an important impact on their estimates of postoperative persistence of OSAS. For example, >50% of patients in the multicenter study of Bhattacharjee et al 133 were obese, whereas 21% of the patients in the series by Ye et al 134 were obese, defined as 95th percentile for the Chinese population. It should be emphasized that although many of these studies showed a high proportion of patients with residual OSAS after AT, most patients exhibited a marked decrease in AHI postoperatively.
Risk Factors for Postoperative OSAS
Obesity
Five studies focused attention on obese patients (defined as 95th percentile for weight or BMI for age), and 1 meta-analysis 131 combined 4 of these studies. The meta-analysis reported that 88% of obese patients still had a postoperative AHI ≥1/hour, 75% had a postoperative AHI ≥2/hour, and 51% had a postoperative AHI ≥5/hour. Preoperative obesity was found to be a significant risk factor for postoperative residual OSAS in several other studies [133] [134] [135] as well, even when multivariable modeling was used to control for other factors such as age and preoperative AHI. The odds ratios of persistent OSAS in obese patients ranged in these models from 3.2 134 to 4.7. 136 One study found that the relationship of BMI to risk of persistent OSAS was no longer significant when adjusted for preoperative AHI. 137 In contrast to all of the studies that looked at this factor, a study of obese Greek children found no difference in the prevalence of residual OSAS in obese versus nonobese children; part of the reason for this finding might be that this study used a slightly less stringent criterion for obesity (1.645 SDs weight for age, which is the 90th percentile). 138 
Baseline Severity of OSAS
All studies that evaluated baseline AHI as a potential risk factor for persistent postoperative OSAS found it to be a significant risk factor, even when adjusted for other comorbidities such as obesity. [132] [133] [134] 136, 139 
Age
A series limited to children aged <3 years reported a high incidence (65%) of treatment failures in these younger children, but this cohort included a large proportion of children who have other risk factors, such as severe OSAS and chromosomal and craniofacial abnormalities. 140 In contrast, 2 studies reported that increasing age (especially 7 years and older) is a risk factor for persistent e734 FROM THE AMERICAN ACADEMY OF PEDIATRICS 
Other Potential Risk Factors
Individual studies have noted that nasal abnormalities or craniofacial disproportion, 141 family history of OSAS, 137 and presence of asthma 133 were all predictive of higher failure rate, but these findings were not substantiated by other studies. Of note, Mitchell 132 found that 13 of 22 patients in the cohort who had postoperative snoring had an AHI ≥5/hour, whereas none of the 57 patients who did not exhibit postoperative snoring had an AHI ≥5/hour. This supports the findings of older studies reviewed in the previous technical report that found absence of snoring to have a 100% negative predictive value for postoperative OSAS. 6 However, in the Chinese cohort, 2 of 11 patients who have persistent AHI ≥5/hour reportedly did not snore; it is unclear whether cultural considerations might have affected parental report of snoring. 134 
Summary
AT is the most effective surgical therapy for pediatric patients, leading to an improvement in polysomnographic parameters in the vast majority of patients. Despite this improvement, a significant proportion of patients are left with persistent OSAS after AT. The estimate of this proportion in a relatively low-risk population ranges from a low of 13% to 29% when using an AHI ≥5/hour as the criterion to a high of 73% when including obese children and adolescents and a conservative AHI ≥1/hour. Children at highest risk of persistent OSAS are those who are obese and those with a high preoperative AHI, especially those with an AHI ≥20/hour, as well as children >7 years of age. Absence of snoring postoperatively is reassuring but may not be 100% specific; it may therefore be advisable to obtain a postoperative PSG in veryhigh-risk children even in the absence of reported persistent snoring.
Areas for Future Research
What are the risks of persistence of OSAS and long-term recurrence of OSAS after PT versus total tonsillectomy? Large, prospective, randomized trials with objective outcome measures including PSG are needed.
Better delineation of which patients would benefit from postoperative PSG.
How well does resolution of OSAS correlate with resolution of complications of OSAS?
Are some of the newer surgical techniques for AT equally effective in resolving OSAS?
What are the risks of performing AT in a patient with a URI?
What are the PSG parameters that predict postoperative respiratory compromise? Future research should focus on refining the AHI and SpO 2 nadir cutoffs for severe OSAS. In addition, it may be possible to glean other predictive information from the PSG, such as the extent of hypoventilation, the percent sleep time spent with SpO 2 <90%, the frequency of desaturation events, the length of apneas and hypopneas, and the presence of central apneas, to create formulae for risk scores.
CPAP
At the time of the previous report, there were few prospective studies on CPAP use in children, although several retrospective studies indicated that CPAP was efficacious in the treatment of pediatric OSAS. Since that time, there have been at least 7 recent studies evaluating the use of positive airway pressure (PAP) in children and adolescents who have OSAS. One of these was a randomized trial with low power (level II), 142 and others were case series without controls (level IV).
A descriptive study examined the use of behavioral intervention in improving CPAP adherence. 143 In addition, a level III study described use of a high-flow nasal cannula as an alternative to CPAP. 144 In contrast to the previous guidelines, several of the current studies obtained objective evaluation of CPAP adherence by downloading usage data from the CPAP device. In most studies, CPAP therapy was instituted for persistent OSAS after AT; in many cases, the patients had additional risk factors for OSAS, such as obesity or craniofacial anomalies.
A multicenter study (level II) evaluated PAP in 29 children who were randomly assigned either CPAP or bilevel positive airway pressure (BPAP). 142 Patients demonstrated significant improvement in sleepiness, snoring, AHI, and oxyhemoglobin saturation while using PAP during the 6-month follow-up period.
However, approximately one-third of patients dropped out, and of those who used PAP, objective adherence was 5.3 ± 2.5 hours/night. Parents overestimated the hours of PAP use compared with the devices' actual objective recordings of use. There was no significant difference in adherence between the CPAP and BPAP groups. A retrospective chart review of 46 children started on PAP for OSAS that persisted after AT also showed significant improvement in symptoms of OSAS as well as in polysomnographic parameters (level IV). 145 Seventy percent of patients were considered adherent. Parental report of adherence was most divergent from the machines' recording in the least adherent patients. More than one-half of the children had complicating factors, such as Down syndrome and Prader-Willi syndrome. 145 Another study of a heterogeneous group of patients displayed varying CPAP adherence, with 31 of 79 children showing continued CPAP use (level IV). 146 A small, nonblinded retrospective study (level IV) suggested that adherence to CPAP could be improved with behavioral techniques if the family accepted the interventions. 143 A retrospective review described 9 children who successfully used BPAP in the intensive care setting because of respiratory compromise after AT. 147 Another retrospective review described the successful use of CPAP in 9 patients of a heterogeneous group of 18 children aged <2 years. 148 A nonrandomized, prospective level III study of 12 children who had OSAS treated in the sleep laboratory with a highflow open nasal cannula system as an alternative to formal CPAP demonstrated an improvement in oxyhemoglobin saturation and arousals, but not AHI, compared with baseline. 144 There was a decrease in sleep efficiency with the cannula compared with baseline. Long-term use and use in the home situation were not assessed.
In summary, several studies (levels II-IV) have confirmed earlier data demonstrating that nasal CPAP is effective in the treatment of both symptoms and polysomnographic evidence of OSAS, even in young children. However, adherence can be a major barrier to effective CPAP use. For this reason, CPAP is not recommended as first-line therapy for OSAS when AT is an option. However, it is useful in children who do not respond adequately to surgery or in whom surgery is contraindicated. Patient and family preference may also be a consideration (eg, in families with religious beliefs against surgery or blood transfusions). Objective assessment of CPAP adherence is important because parental estimates of use are often inaccurate. If the patient is nonadherent, then attempts should be made to improve adherence (eg, by addressing adverse effects, by using behavior modification techniques), or the patient should be treated with alternative methods. A study described in the previous report noted that CPAP pressures change over time in children, presumably because of growth and development. 149 Therefore, it is recommended that CPAP pressures be periodically reassessed in children.
At this time, data are insufficient to make a recommendation on the use of high-flow, open nasal cannula systems.
Areas for Future Research
Efficacy of CPAP use as a first-line treatment of obese children.
Determinants of CPAP adherence and ways to improve adherence.
Long-term effects of CPAP, particularly on the development of the face, jaw, and teeth.
Changes in CPAP pressure over time, and the frequency with which this needs to be monitored.
Development of pediatric-specific devices and interfaces.
Medications
There have been several studies evaluating the use of corticosteroids and leukotriene antagonists in the treatment of OSAS. An older study showed no therapeutic effect of systemic steroids on OSAS. 150 Since then, 3 studies (1 level I, 1 level II, and 1 level III) have evaluated topical nasal steroids as treatment of OSAS, 1 level II study has evaluated montelukast, and 1 level IV study has evaluated a combination thereof. An additional level I study evaluated the effect of intranasal steroids on adenoidal size and symptoms related to adenoidal hypertrophy but did not include PSG in the evaluation. 151 A small, level II, randomized, doubleblind trial, 152 a level I, randomized, double-blind trial of 62 children, 153 and a nonrandomized, open-label level III study of intranasal steroids 154 all showed a moderate improvement in patients who had mild OSAS. However, significant residual OSAS remained in 2 of the studies. Berlucchi et al 151 reported an improvement in symptoms of adenoidal hypertrophy, including snoring and observed apnea, but did not obtain objective evidence of improvement in OSAS. Two studies showed shrinkage of adenoidal tissue. 151, 153 All studies were short term (2-6 weeks), although 1 study showed persistent improvement 8 weeks after discontinuation of the steroids (Table 18) . 153 An open-label, nonrandomized, 16-week level IV study of montelukast in children who had mild OSAS found a statistically significant but small change in the AHI (AHI decreased from 3.0 ± 0.2 to 2.0 ± 0.3; P = .017). 82 Another small, open-label, nonrandomized, 12-week level IV study of combined montelukast and nasal steroids found a mild but statistically significant improvement in AHI in children who had mild OSAS (AHI decreased from 3.9 ± 1.2/hour to 0.3 ± 0.3/hour; P < .001). 155 In summary, several small level I through IV studies suggest that topical steroids may ameliorate mild OSAS. However, the clinical effects are small. On the basis of these studies, intranasal steroids may be considered for treatment of mild OSAS (defined, for this indication, as an AHI <5/hour, on the basis of studies described in Table 18 ). Steroids should not be used as the primary treatment of moderate e738 FROM THE AMERICAN ACADEMY OF PEDIATRICS or severe OSAS. Because the longterm effects of intranasal steroids are not known, follow-up evaluation is needed to ensure that the OSAS does not recur and to monitor for adverse effects. Of note, no studies specifically evaluated children who had atopy or chronic rhinitis, although 1 study mentioned that similar improvements were seen in children who had a history of allergic symptoms compared with those without. 153 Further study to determine whether children who have atopy are more likely to respond to this therapy is needed. Data are insufficient at this time to recommend treatment of OSAS with montelukast.
Areas for Future Research
What is the optimal duration of intranasal steroid use? All trials have been short-term with a short-term follow-up. Does the OSAS recur on discontinuation of therapy? How often should objective assessment of treatment effects be performed?
What is the efficacy of intranasal steroids in children who have chronic or atopic rhinitis?
How do the benefits and adverse effects of long-term nasal steroids compare with surgery?
Larger studies, stratified for severity of OSAS and controlled for obesity, to determine whether OSAS is associated with systemic inflammation Will these biomarkers be good outcome measurements for treatment studies? Do they correlate with clinical outcomes or long-term prognosis?
Rapid Maxillary Expansion
Rapid maxillary expansion has recently been used to treat OSAS in select pediatric populations. It is an orthodontic procedure designed to increase the transverse diameter of the hard palate by reopening the midpalatal suture. It does this by means of a fixed appliance with an expansion screw anchored on selected teeth. After 3 to 4 months of expansion, a normal mineralized suture is built up again. The procedure is typically used only in children with maxillary constriction and dental malocclusion. Two case series without controls (level IV) have evaluated this procedure as a treatment of OSAS in children. One study described 31 patients selected from an orthodontic clinic; 4 months after surgery, all patients had normalized AHI. 156 Another screened 260 patients in a sleep center to find 35 that were eligible; only 14 were studied. 157 There was a significant improvement in signs and symptoms of OSAS as well as polysomnographic parameters. In summary, rapid maxillary expansion is an orthodontic technique that holds promise as an alternative treatment of OSAS in children. However, data are insufficient to recommend its use at this time.
Areas for Future Research
A randomized controlled trial to assess the efficacy of rapid maxillary expansion in the treatment of OSAS in children.
Positional Therapy
Several level IV, retrospective studies evaluated the effect of body position during sleep on OSAS. The studies had conflicting results. One study found that young children had an increased AHI in the supine position, 158 and another study found that young children did not have a positional change in AHI but older children did. 159 Another study found an increased obstructive apnea index but not AHI (except in the obese subgroup) in the supine position, 160 whereas a study of obese and nonobese children, which controlled for sleep stage in each position, found that AHI was lowest when children were prone. 161 No study evaluated the effect of changing body positions or the feasibility of maintaining a child in a certain position overnight. Therefore, at this point, no recommendations can be made with regard to positional therapy for OSAS in children.
Other Treatment Options
Specific craniofacial procedures, such as mandibular distraction osteogenesis, are appropriate for select children with craniofacial anomalies. However, a discussion of these children is beyond the scope of this guideline. Minimal experience is available regarding intraoral appliances in children. 162 A tracheotomy is extremely effective at treating OSAS but is associated with much morbidity and is typically a last resort if CPAP and other treatments fail to offer improvement for a child who has severe OSAS.
OBESITY AND OSAS
This section reviews the evidence regarding the relationships between obesity and SDB (this term is used to encompass both snoring and OSAS, especially in studies that did not distinguish between these entities) in the pediatric population. The prevalence of childhood obesity is increasing, 163 and many studies on obesity and OSAS have been published since the last guideline. Because childhood obesity has a major impact on OSAS, it is described in detail in this report. Obesity is defined as BMI >95th percentile for age and gender.
Epidemiology: Obesity as a Risk Factor for Snoring and OSAS
A number of large, cross-sectional, community-based studies including more than 21 500 children have examined the risk of SDB conferred by overweight and obesity (Table 19 ). The majority of these studies obtained information regarding potential SDB from questionnaires, but some included objective measurements such as oximetry or overnight PSG. Similarly, many studies based the determination of BMI on data from questionnaires. The ages ranged from 6 to 17 years, consistent with recruitment strategies using local schools. Countries from around the world are represented, including North America, Asia, Europe, and the Middle East. Taken together, these studies indicate that the risk of snoring in children is increased twofold to fourfold with obesity (defined as BMI ≥90th or 95th percentile). When analyzed, BMI was found to be an independent risk factor for snoring.
Several studies based on surveys of thousands of children, in some cases supplemented by use of physical examinations, showed that overweight/ obesity was associated with an increased prevalence of snoring (Table  19) . 47, [164] [165] [166] [167] Fewer studies that included objective measurements to identify SDB were available. Two population-based studies using PSG demonstrated a relationship between overweight/obesity and OSAS. 11, 12 In contrast to the findings of the majority of studies, Brunetti et al 23 found that although HS was more prevalent in obese children in a sample of schoolchildren, there was no difference in the incidence of OSAS on PSG among the subset of normalweight, overweight, and obese children who have HS who had abnormal overnight oximetry results. Similar to the population-based studies, studies using case series or subjects recruited from sleep disorders programs (some of which use PSG and some of which use surveys) also showed a relationship between weight and SDB. 168, 169 From these studies, it can be concluded that obesity is an independent risk factor for snoring and OSAS. The range of evidence from individual studies was II to III (Table 19 ) and on the aggregate rise to level I. The studies reported on large numbers of children recruited from communitybased samples, some of whom had face-to-face examinations and measurements. Data obtained in different settings yielded similar results. The impact of race, if any, is not yet clear. Population-based studies of Hispanic children, a group at high risk of obesity and related comorbidities, are not yet available. 163 For the clinician, it is recommended that particular attention is needed for screening obese and overweight children for signs and symptoms of OSAS, with a low threshold for ordering diagnostic tests. Future research should focus on population-based studies, with objective measurements of both measures of adiposity and PSG, and should include larger numbers of African American and Hispanic youth.
Predictors of Obesity-Related SDB
A number of program-based studies provide information regarding the predictors for SDB in obese children. Carotenuto et al 88 reported via data gathered from parental questionnaires that in obese subjects referred for obesity evaluation and nonobese controls randomly selected from schools, the waist circumference z score correlated with symptoms of SDB (R = 0.37, P < .006) but BMI and subcutaneous fat did not (level III). Verhulst et al 170 examined 91 consecutive overweight or obese children referred for PSG and found that OSAS was not related to indices of obesity, including bioelectric impedance analysis fat mass (level III). Central apnea was significantly predicted by using BMI score, waist circumference, waistto-hip circumference ratio, and percent fat mass. Tonsillar size was the only significant correlate in their model for moderate to severe OSAS. In a retrospective review of 482 Chinese children referred for PSG and evaluated by using BMI and a tonsillar grading scale, the group of 111 obese children had a significantly higher median AHI and percentage with AHI >1.5/hour than did the nonobese group (level III). 171 In a regression analysis of log AHI as dependent variable, BMI and tonsil grade were predictors, but age and gender were not. In a large study of schoolchildren in e740
FROM THE AMERICAN ACADEMY OF PEDIATRICS Tanner stage was determined by selfattestation. In the prepubertal children, they found no association between polysomnographic parameters and metabolic measurements after correcting for BMI. Elevated fasting insulin (≥20 μU/mL) was significantly more common in the OSAS group (P = .03), even when corrected for BMI. When pubertal obese subjects were considered separately, the risk of elevated fasting insulin (P = .04) and impaired HOMA was greater in the OSAS group (P = .05). Pubertal children who had OSAS also had lower adiponectin and higher urinary catecholamine levels, even when controlled for BMI. Kelly et al concluded that OSAS further predisposes obese children to metabolic syndrome, likely through multiple mechanisms involving adipose tissue and the sympathetic nervous system.
In a study that included pretreatment and posttreatment measurements in 62 prepubertal children who had moderate to severe OSAS, Gozal et al 184 found that although nonobese children had no change in measures of glucose homeostasis after treatment of OSAS, obese children had a significant improvement even while BMI remained stable (P < .001) (level II). Similar effects were not seen in nonobese children. Treatment (AT) improved the lipid profile and inflammatory markers in both obese and nonobese children.
Other studies have examined different aspects of altered metabolism in obesity-related OSAS. KheirandishGozal et al 185 found elevated alanine transaminase (a marker for fatty liver) in a large sample of obese children who had OSAS (level IV). Verhulst et al 186 found elevated serum uric acid (a marker of oxidative stress) in 62 overweight children who had OSAS, with a significant relationship between the severity of OSAS and serum uric acid independent of abdominal adiposity (P = .01) (level IV They reported that the obese group had later bedtimes (P < .05), shorter (P < .01) and more disrupted sleep (P < .05), more symptoms of OSAS (P < .001), sleepiness (P = .009), parasomnias (P = .007), higher AHI (P < .01), and poorer school performance. Another study by Beebe et al 190 of 263 overweight subjects enrolled in a hospital-based weightmanagement program found a negative relationship between the severity of OSAS and school performance and parent-and teacher-reported behaviors that persisted with adjustment for gender, race, SES, sleep duration, and BMI (level IV). Interestingly, Roemmich et al 191 found a relationship between a decrease in motor activity and increasing weight in overweight children after surgical treatment of OSAS by using AT (P = .03) (level IV). They hypothesized that a decrease in physical activity and "fidgeting" energy expenditure were responsible for the weight gain. However, because obese controls without surgery were not studied, it is unclear whether the degree of weight gain was greater than typically seen in obese children.
In summary, these studies point to obesity as a potential important factor in childhood performance, mood, and behavior (aggregate level III IV) . They found that OSAS did not differ between obese and nonobese children and that there was no difference in QoL between children who snore and have OSAS. The referred SDB group had lower QoL scores than the control group (P < .001), but the authors found no difference between obese and nonobese SDB subjects or in those with OSAS versus snoring. They concluded that children who snore have a lower QoL than nonsnoring controls, and that this finding was not related to obesity of the severity of SDB.
In summary, QoL is an important outcome measure that may be more related to perceived symptoms of OSAS than measured physiologic disturbances of sleep and breathing, even in the obese patient (aggregate level IV). The impact of obesity on QoL in children with SDB is yet to be determined by using population-based studies and is an important outcome measure to be included in longitudinal and treatment studies.
Surgical Treatment of OSAS in the Obese Child
Surgical treatment of OSAS in general is discussed in detail in the technical report, but 5 studies have examined this area in obesity-related OSAS and are discussed here. Shine et al 194 evaluated 19 obese patients treated with AT (level IV). Although OSAS improved significantly (P < .01), only 37% of patients were deemed cured (defined as a postoperative AHI <5/ hour), and 10 (53%) subjects needed CPAP postoperatively. A level IV retrospective review by Spector et al 195 included 14 patients who were morbidly obese who were electively sent to the ICU after AT (per policy). One patient needed intubation, and 2 patients required BPAP. Another retrospective review of 26 morbidly obese patients, all of whom were sent to the ICU after AT as per routine, found that 14 patients (54%) had an uncomplicated postoperative course, and 12 (45%) required respiratory intervention, including 1 requiring intubation and 2 requiring BPAP. 196 Costa and Mitchell 131 evaluated the response to AT in a meta-analysis of 4 studies that included 110 obese children who had OSAS (level III). They found that OSAS improved but did not resolve after AT, with 88% of children having an AHI >1/hour and 51% of children having an AHI >5/hour postoperatively. Apostolidou et al 138 reported on 70 snoring children with a mean age of 5.8 ± 1.8 years who underwent AT; 22 (31%) were obese (level IV). PSG was performed both preoperatively and postoperatively. They found no difference in cure rates between obese and nonobese subjects who had OSAS, by using an AHI <1/hour as the definition of cure. However, there was an improvement in AHI in both groups, and approximately 90% of all subjects had an AHI <5/hour postoperatively.
In summary, few studies have evaluated the effects of AT in the obese child who has OSAS, and studies have been of a low level of evidence (aggregate level IV). Studies suggest that the AHI may improve significantly after AT, even in obese children, supporting the idea that surgery may be a reasonable first-line treatment, even in obese patients. However, better-level studies are needed to assess the effects of AT in obese children and adolescents, including evaluation of subgroups such as adolescents and the morbidly obese. A significant number of children required intubation or CPAP postoperatively, which reinforces the need for inpatient observation in obese children postoperatively. Studies have not been performed to determine whether children at high risk who are obese and have OSAS, such as those with pulmonary or systemic hypertension, waking hypoventilation, or pathologic daytime sleepiness, may benefit from stabilization with BPAP therapy before undergoing AT to decrease the risk of postoperative complications.
Weight Loss and Other Nonsurgical Treatments
There is a paucity of data regarding the effects of weight loss on OSAS in children and adolescents. Verhulst et al 197 found that weight loss was a successful treatment of OSAS in a group of 61 adolescents being cared for in a residential weight loss treatment program (level IV). Davis et al 49 studied the effects of exercise in 100 overweight children by administering the Pediatric Sleep Questionnaire before and after enrollment in a noexercise group, a low-dose aerobic exercise program, or a high-dose aerobic exercise program for 3 months (level IV). They found no change in BMI, but 50% of children who screened positive for SDB improved to a negative screening result after intervention. They found their results to be consistent with a dose-response effect of exercise on improvement in SDB (P < .001). Academic achievement did not improve in concert with changes in the Pediatric Sleep Questionnaire. Kalra et al 198 showed a significant improvement in OSAS after bariatric surgery, in association with a mean weight loss of 58 kg (level IV). In summary, along with many other health-related benefits, achieving weight loss and increasing exercise seem to be beneficial for OSAS and should be recommended along with other interventions for OSAS in obese children and adolescents (aggregate level IV). However, it should be noted that the 2 weight loss studies involved treatment regimens that are not commonly available to the majority of obese children. The effects of more modest weight loss regimens require further evaluation.
Pulmonary Disease and Obesity-Related SDB
Two studies addressed the relationship between obesity-related SDB and pulmonary disease. This has been described in adults as the "overlap syndrome," when chronic obstructive pulmonary disease and OSAS are present in the same individual. As part of the Cleveland Children' s Sleep and Health Study, Sulit et al 199 evaluated parent-reported wheeze and asthma, history of snoring, and PSG in 788 participants (level III). They found that children who experienced wheeze and asthma were more likely to be obese (P = .0097) and concluded that SDB may partially explain this finding. They speculated that obesity changes airway mechanics and that SDB may increase gastroesophageal reflux, leptin levels, and cytokines and, thus, increase lower airways inflammation. Dubern et al 200 studied 54 children who had BMI z scores >3, 74% of whom were pubertal, by using history, physical examination, assessment of body fat mass, Tanner stage, HOMA, lipid profile, leptin, pulmonary function tests, and PSG (level IV). They confirmed the presence of OSAS, lower functional residual capacity, increased airways resistance, lower airways obstruction, and insulin resistance in this group of morbidly obese children. Snoring and AHI correlated with BMI (P = .01) and neck/height ratio (P = .03) (adjusted for age, gender, Tanner stage, and ethnicity). Airways resistance correlated with snoring index and AHI after adjustment. These studies remind us that the upper airway is part of the respiratory system and that its function is affected by lung mechanics. Abnormalities of pulmonary mechanics related to obesity affect OSAS and may add to abnormalities of gas exchange during sleep. It is suggested that evaluation of the child who is obese and has OSAS should include a history and physical examination directed at the entire respiratory system, and pulmonary function testing may be indicated. 
Areas for Future Research
